CJC-1295 Without DAC 2mg

$34.00

Tetrasubstituted 29-amino acid peptide analog prepared for targeted endocrine signaling assays. Provided as a stabilized 2mg lyophilized solid in an amber-shielded glass vial.

At a glance

LPPeptide

CP10

Specification

10mg x 10 vials (CJC-1295 5mg + Ipamorelin 5mg) /box

Category

Performance & Growth

Form

Lyophilized powder

Knowledge source

CJC-1295 + Ipamorelin (CP10)

Research focus

Performance & Growth

Reconstitution

LPPEPTIDE knowledge source: add 3.0 mL sterile water for about 3.33 mg/mL total, about 1.67 mg/mL for each peptide. Reference range is once daily 100-300 mcg of each peptide. At this concentration, 1 U provides about 33.3 mcg of each peptide.

Storage

Lyophilized: -20 deg C, dry and dark. Reconstituted: 2-8 deg C, use within about 28 days, and avoid freeze-thaw.

COA

View certificate

Batch

CP10260616

What is CP10?

GH-axis blend profile pairing CJC-1295 without DAC and Ipamorelin. The LPPEPTIDE knowledge record describes CP10 as a fixed blend of CJC-1295 without DAC, a modified GHRH analog, with Ipamorelin, a selective growth hormone secretagogue. The source highlights GH and IGF-1 marker increases from CJC-1295 and selective GH release without ACTH or cortisol increase from Ipamorelin. CJC-1295 Without DAC + Ipamorelin 10mg is mapped to LPPeptide SKU CP10. Current storefront values use our product data: 10mg x 10 vials (CJC-1295 5mg + Ipamorelin 5mg) /box, $106.00 USD per box. LPPeptide reference specs: 10mg x 10 vials (CJC-1295 5mg + Ipamorelin 5mg).

Research context

The LPPEPTIDE knowledge record describes CP10 as a fixed blend of CJC-1295 without DAC, a modified GHRH analog, with Ipamorelin, a selective growth hormone secretagogue. The source highlights GH and IGF-1 marker increases from CJC-1295 and selective GH release without ACTH or cortisol increase from Ipamorelin. Research usually focuses on pulsatile GH-axis signaling, GHRH receptor context, ghrelin receptor selectivity, and IGF-1 pathway markers.

Commonly matched with

CP10 is commonly reviewed alongside IP10, SMO-10, CJC-1295, Ipamorelin, Sermorelin. Keep each combination tied to a defined research objective and lot record.

Compliance notice

CP10 is supplied for research use only. It is not for human or veterinary use, not for consumption, and statements on this page are reference context rather than medical claims.

Research

Reference literature focus

The LPPEPTIDE knowledge record describes CP10 as a fixed blend of CJC-1295 without DAC, a modified GHRH analog, with Ipamorelin, a selective growth hormone secretagogue. The source highlights GH and IGF-1 marker increases from CJC-1295 and selective GH release without ACTH or cortisol increase from Ipamorelin. Research usually focuses on pulsatile GH-axis signaling, GHRH receptor context, ghrelin receptor selectivity, and IGF-1 pathway markers.

Study design notes

Use the LPPeptide product knowledge record, current LPPeptide COA, and internal lab SOP to confirm identity, concentration, and endpoints before this material enters a study. The matched LPPeptide reference specification is 10mg x 10 vials (CJC-1295 5mg + Ipamorelin 5mg).

Dosing & Protocol

LPPeptide handling reference

LPPEPTIDE knowledge source: add 3.0 mL sterile water for about 3.33 mg/mL total, about 1.67 mg/mL for each peptide. Reference range is once daily 100-300 mcg of each peptide. At this concentration, 1 U provides about 33.3 mcg of each peptide.

LPPEPTIDE preparation pattern: use sterile technique, add diluent slowly down the vial wall, avoid foaming, roll gently until dissolved, label the preparation date, refrigerate at 2-8 deg C, and protect from light.

Preparation

CJC-1295 Without DAC + Ipamorelin 10mg ships as Lyophilized powder. Reconstitution note: LPPEPTIDE knowledge source: add 3.0 mL sterile water for about 3.33 mg/mL total, about 1.67 mg/mL for each peptide. Reference range is once daily 100-300 mcg of each peptide. At this concentration, 1 U provides about 33.3 mcg of each peptide.. Record the final concentration and preparation date in the study log.

Storage

Lyophilized: -20 deg C, dry and dark. Reconstituted: 2-8 deg C, use within about 28 days, and avoid freeze-thaw.. Follow the most current lot-specific handling record whenever it is available.

Side Effects

Safety observations

Review GH-axis sensitivity, glucose markers, water retention signals, and combination-specific uncertainty.

Contraindications

Do not use CP10 outside qualified research workflows. Review the current SDS, COA, and protocol exclusions before handling.

Interaction review

Review combinations with sermorelin, tesamorelin, CJC-1295 with DAC, or IGF-axis materials.

COA & Testing

Certificate of Analysis

Each LPPeptide lot should be confirmed against current batch documentation before shipment or study use. This product page keeps CP10 visible so the SKU can be matched to the active COA.

Current catalog summary

  • SKU: CP10

  • Product: CJC-1295 Without DAC + Ipamorelin 10mg

  • Storefront specification: 10mg x 10 vials (CJC-1295 5mg + Ipamorelin 5mg) /box

  • LPPeptide reference specs: 10mg x 10 vials (CJC-1295 5mg + Ipamorelin 5mg)

  • Listed box price: $106.00 USD

  • Reference: LPPeptide product knowledge record

Testing checklist

  • Peptide identity or material identity

  • HPLC purity or assay result where applicable

  • Batch ID and test date

  • Sterility/endotoxin or accessory checks when applicable

  • Residual solvent and handling notes where applicable